Evidence map›Paper›PMID 37328541›Full record

ArticleLeukemia2023

Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group.

Lucille Lew-Derivry, Alice Marceau-Renaut, Laurène Fenwarth, Wendy Cuccuini, Paola Ballerini, Maxime Ferreboeuf, Audrey Guilmatre, Arnaud Petit, Virginie Gandemer, Fanny Rialland and 7 more

Open access · hybridAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Lucille Lew-DerivryAP-HP, Pediatric Hematology and Oncology Department, Trousseau Hospital, F-75012, Paris, France. l.derivry@gmail.com.ORCID 0000-0002-6419-2801
Alice Marceau-RenautCHU Lille, Laboratory of Hematology, F-59000, Lille, France.
Laurène FenwarthCHU Lille, Laboratory of Hematology, F-59000, Lille, France.ORCID 0000-0003-2808-4843
Wendy CuccuiniAP-HP, Department of cytogenetics, Saint-Louis Hospital, F-75010, Paris, France.
Paola BalleriniAP-HP, Laboratory of Hematology, Trousseau hospital, F-75012, Paris, France.
Maxime FerreboeufAP-HP, Pediatric Hematology and Oncology Department, Trousseau Hospital, F-75012, Paris, France.
Audrey GuilmatreAP-HP, Pediatric Hematology and Oncology Department, Trousseau Hospital, F-75012, Paris, France.
Arnaud PetitAP-HP, Pediatric Hematology and Oncology Department, Trousseau Hospital, F-75012, Paris, France.ORCID 0000-0001-8363-1622
Virginie GandemerDepartment of Pediatric Hematology/Oncology, University Hospital of Rennes, F-35000, Rennes, France.
Fanny RiallandDepartment of Pediatric Hematology/Oncology, University Hospital of Nantes, F-44000, Nantes, France.ORCID 0000-0002-3136-6270
Pascale SchneiderDepartment of Pediatric Hematology/Oncology, University Hospital Charles-Nicolle, F-76000, Rouen, France.
Gérard MichelAP-HM, Department of Pediatric Hematology, La Timone University Hospital, F-13000, Marseille, France.
Yves BertrandHospices civils de Lyon, Institute of Hematology and Oncology Pediatrics, F-69000, Lyon, France.
Andre BaruchelAP-HP, Department of Pediatric Hematology and Immunology, Robert Debre University Hospital, F-75019, Paris, France.ORCID 0000-0003-0120-6089
Claude PreudhommeCHU Lille, Laboratory of Hematology, F-59000, Lille, France.
Guy LevergerAP-HP, Pediatric Hematology and Oncology Department, Trousseau Hospital, F-75012, Paris, France.
Hélène LapillonneAP-HP, Laboratory of Hematology, Trousseau hospital, F-75012, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRInserm · FRCentre Hospitalier Universitaire de Lille · FRCentre Hospitalier Universitaire de Rennes · FRHôpital Charles-Nicolle · FRHospices Civils de Lyon · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Core Binding Factor Alpha 2 SubunitLeukemia, Myeloid, AcuteChildHumansMutationPrognosisCore Binding Factor Alpha 2 SubunitRUNX1 protein, human

Identifiers

PMID37328541
PMCPMC10400410
OpenAlexW4380987001

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.